Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Angiotensin-converting enzyme 2 augments the effects of endothelial progenitor cells-exosomes on vascular smooth muscle cell phenotype transition.

Cell and tissue research - 1 Dec 2020

Wang Jinju, Li Jiao, Cheng Chuanfang, Liu Shiming

Abstract excerpt

Phenotype transition of vascular smooth muscle cells (VSMCs) is implicated in vascular diseases. Angiotensin-converting enzyme 2 (ACE2) is a perspective cardiovascular target due to its ability of converting angiotensin (Ang II) to Ang (1-7). Our group recently showed that ACE2 can regulate the function of endothelial progenitor cell-derived exosomes (EPC-EXs). Here, we investigate whether ACE2 could affect the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme 2
Share to Endothelial Progenitor Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Exosomes

Share to Myocytes, Smooth Muscle

Share to Phenotype

Share to Transfection

Source

Identifiers

PMID: 32852610
DOI: 10.1007/s00441-020-03259-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Angiotensin-converting enzyme 2 augments the effects of endothelial progenitor cells-exosomes on vascular smooth muscle cell phenotype transition.PMID 32852610Read ↗

SARS-CoV-2 induced vascular endothelial dysfunction: direct or indirect effects?Semantic proximity Read ↗

Contribution of extracellular vesicles to human pulmonary arterial smooth muscle cell dysfunction in congenital heart disease-associated pulmonary arterial hypertensionSemantic proximity Read ↗

Endothelial-to-mesenchymal transition: A novel therapeutic target for cardiovascular diseases.Semantic proximity Read ↗

Exosomes: mediators regulating the phenotypic transition of vascular smooth muscle cells in atherosclerosis.Semantic proximity Read ↗

SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein.Semantic proximity Read ↗

Dexmedetomidine protects cells from Angiotensin II-induced smooth muscle cell phenotype switch and endothelial cell dysfunction.Semantic proximity Read ↗

LncRNA LINC00281/Annexin A2 Regulates Vascular Smooth Muscle Cell Phenotype Switching via the Nuclear Factor-Kappa B Signaling Pathway.Semantic proximity Read ↗

AK098656, a Novel Vascular Smooth Muscle Cell-Dominant Long Noncoding RNA, Promotes Hypertension.Semantic proximity Read ↗

Endothelial-derived extracellular microRNA-92a promotes arterial stiffness by regulating phenotype changes of vascular smooth muscle cells.Semantic proximity Read ↗

Upregulation of TRPM7 channels by angiotensin II triggers phenotypic switching of vascular smooth muscle cells of ascending aorta.Semantic proximity Read ↗

Exosome miR-199a-5p modulated vascular remodeling and inflammatory infiltration of Takayasu's arteritisSemantic proximity Read ↗

A promising field: regulating imbalance of EndMT in cardiovascular diseases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.